Advertisement

Topics

Companies Related to "Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)" [Most Relevant Company Matches] RSS

09:36 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Effectiveness Plus Combination Chemotherapy Subjects With Small" Companies 1–25 of 3,500+

Relevant

Sonrgy, Inc.

Sonrgy is a preclinical stage biotechnology company based in San Diego, California that is developing a targeted chemotherapy delivery platform to improve survival and quality of life for millions of cancer patients. Sonrgy’s tiny nanocarriers safely transport potent chemotherapy drugs to cancer tumors and release high doses on command in response to a focus...


Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-can...


Medifocus Inc.

Medifocus owns a patented microwave focusing technology platform the Adaptive Phased Array ("APA") system, which can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation. The ability to target tumors with a precision controlled dose of hea...

Medifocus, Inc.

Medifocus owns a patented microwave focusing technology platform the Adaptive Phased Array ("APA") system, which can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation. The ability to target tumors with a precision controlled dose of hea...

RND Pharmaceuticals, Inc

RND Pharmaceuticals, Inc. is an emerging biopharmaceutical company that designs and develops proprietary small molecule therapeutics to address unmet medical needs. RND applies a unique medicinal chemistry approach to the development of innovative pharmaceuticals. This approach focuses on existing and approved drugs as templates for modification to enhance drug effectiveness, increase safety, and ...

Drug Safety Alliance

Founded in 2000, Drug Safety Alliance (DSA) provides patient safety and pharmacovigilance expertise to large and small pharmaceutical and biotechnology companies to help them develop safe drugs and improve patient safety. Driven by the highest ethical standards, DSA is uniquely focused to provide high-quality pre- and post-market drug safety services inclu...

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...

425 Inc.

Founded in 2010 and headquartered in Mount Pleasant, Wis., 425 Inc. is a personal safety device company. Its Guardian Angel product line represents the industry’s first small, wearable lighted device designed to improve personal safety – both in the workplace and out.

DiaTech Oncology

DiaTech Oncology is a privately held clinical pathology laboratory that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. DiaTech utilizes a patented technology called the Microculture Kinetic (MiCK) assay, which measures apoptosis (cell death) induced in a specific patient’s...

resTORbio, Inc.

resTORbio, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. resTORbio’s lead program is targeting the target of rapamycin complex 1 (TORC1) pathway to treat aging-related diseases and conditions with an initial focus on conditions caus...

Q'Straint

For over 25 years, Q'Straint has remained focused on one mission: To develop the most innovative solutions that advance the safety and effectiveness of wheelchair passenger travel. Our reputation as a global leader is the result of making transportation safety and customer needs the highest priority. We are committed to continued product leadership and inn...

Kepivance™ (palifermin)

Kepivance™ (palifermin) is indicated to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients withhematologic (blood) cancers undergoing high-dose chemotherapy, with or without radiation, followed by bone marrow transplant. The safety and efficacy of Kepivance™ have not been established in patients with nonhematologic malignancies.

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

MacuSight, Inc.

MacuSight is a privately-held pharmaceutical company focused on developing innovative therapeutics for the treatment of severe ocular diseases and conditions. The company is dedicated to preserving patients' vision by identifying known, highly-potent and broad-acting small molecule drug compounds that may possess efficacy in treating and/or preventing diseases or conditions of the eye. As part...

Ulthera, Inc.

Ulthera, Inc. develops and markets innovative medical devices that leverage the proven power and safety of ultrasound for rejuvenation of the skin and its support structures. Treatment with the Ulthera System enables dermatologists, plastic surgeons and facial plastic surgeons, for the first time, to non-invasively see and treat at prescribed depths below the skin's surface, resulting in significa...

Goodwyn IRB

Goodwyn means "good friend" and The Goodwyn IRB® is a good friend to pharmaceutical manufacturers, contract research organizations, site management organizations and the human subjects involved in clinical research studies.Actually, The Goodwyn IRB is a unique group of good friends – experts from all over North America, chosen for their expertise and reputation to provide the highest level of r...

Advanced Sterilization Products

Advanced Sterilization Products (ASP) division of Ethicon, Inc., is a leading developer of innovative instrument sterilization, high-level disinfection, and cleaning technologies. The company is dedicated to protecting patients, healthcare workers, and the environment with products that focus as much on safety as they do on efficacy and cost-effectiveness. Utilizing advanced instrument processing ...

Carbylan BioSurgery, Inc.

Carbylan (www.carbylan.com) was founded in 2005 to develop and market medical devices and device/drug combination products based on novel chemically engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body. Its initial market focus is therapeutic medical devices and combination products to treat...

Outcomes Pharmaceutical Health Care

Outcome is the leading provider of patient registries, studies, quality improvement programs, and integrated technologies for evaluating real-world outcomes. Outcome provides services and technologies focused on evaluating the safety, effectiveness, and quality of healthcare products and services. The company has designed, developed, and managed an industr...

REGISTRAT®, Inc

REGISTRAT Mission Statement is To partner with our sponsors, the scientific community, healthcare providers and patients to conduct quality research, advance scientific knowledge, gain clinical insights, and optimize the effectiveness and safety of medical products.

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...

Impact Education, LLC

IE is an independent medical education and communications company dedicated to providing high quality educational programs. IE’s mission is to develop education that improves patient outcomes in combination with increased health care efficiency and cost-effectiveness. The majority of activities developed by IE are focused on the needs of the managed c...

HealthCore Inc.

HealthCore, based in Wilmington, Del., is the clinical outcomes research subsidiary of WellPoint, Inc. HealthCore has a team of highly experienced researchers including physicians, biostatisticians, pharmacists, epidemiologists, health economists and other scientists who study the “real world” safety and effectiveness of drugs, medical devices an...

Clinical Research Associate

Clinical Research Associate, also known as a Monitor, is an individual that oversees the progress and conduct of a clinical trial. A clinical trial is usually implemented by physicians at a hospital, clinic, or physician's office. The CRA is required to oversee the initiation, progress, and conduct of the clinical trial to ensure the scientific integrity of the data collected, and the protection o...


More From BioPortfolio on "Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks